European Lithium's Greenland Green Light and a Boston Fund's Bet Tighten the Merger Noose
Published on 08/11/2026 at 03:05 | Redaktion boerse-global.deThe countdown to European Lithium's absorption by Critical Metals Corp has entered a phase where the regulatory stars are aligning faster than the paperwork can keep up. With scheme meetings penciled in for late August and implementation targeted for early September, the company's latest quarterly filing has landed alongside a pair of developments that underscore just how far the transaction has travelled since the two parties first shook hands on a non-binding agreement back on 25 April.
Greenland's Sign-Off Adds a Strategic Feather
The most consequential update to emerge from the quarterly report concerns Tanbreez, the rare earths project that sits at the heart of the combined group's future value proposition. The Greenland government has formally approved the transfer of the remaining 50.5 percent stake in Tanbreez to Critical Metals, lifting the company's ownership to 92.5 percent. That regulatory clearance removes a significant hurdle from the merger path, given that Tanbreez is widely regarded as the cornerstone asset of the post-deal entity.
Work on the ground in Greenland is already accelerating. Critical Metals has broken ground on a multi-purpose warehouse in Qaqortoq, complete with its own laboratory and pilot plant, and has allocated US$30 million under a Project Acceleration Plan covering drilling, sample extraction and contractor appointments. The diamond drilling campaign at Tanbreez, budgeted at 10,000 metres in total, had reached three completed holes totalling roughly 702.4 metres by the end of the quarter — early but tangible evidence that the development engine is turning.
A Boston Fund Builds a Position
Alongside the operational momentum, the shareholder register has been stirring. Weiss Asset Management LP has disclosed a substantial holding of 5.06 percent in European Lithium, equivalent to 87,349,781 ordinary shares. The Boston-based fund began accumulating the position back in May, paying between US$0.3864 and US$0.4806 per share, according to its own filings.
The timing of those purchases is telling. They coincide with the period when European Lithium and Critical Metals were converting their April heads of agreement into the binding Scheme Implementation Deed signed in May — and they sit comfortably ahead of the shareholder votes expected later this month. Institutional accumulation of this kind, at a fixed exchange ratio, often signals arbitrage positioning around the merger spread rather than a long-term fundamental view.
Should investors sell immediately? Or is it worth buying European Lithium?
Insiders have also been signalling their confidence in the deal's completion. On 24 July, company directors exercised options priced at A$0.08 each, disclosed via Appendix 3Y notices. Such exercises, coming weeks before a scheme vote, are typically read by the market as a bet that the transaction will indeed close.
The Mechanics of the All-Scrip Deal
The transaction structure itself remains unchanged from the terms announced in May. Under the scheme implementation deed, European Lithium shareholders will receive 0.035 Critical Metals shares for each share they hold — an all-scrip arrangement with no cash component. Post-completion, existing European Lithium holders are expected to own approximately 41 percent of the combined company's outstanding ordinary shares.
One condition continues to loom large: European Lithium must hold at least A$330 million in net cash and liquid assets at the point of implementation. The company's quarter-end cash position stood at US$296.3 million, a figure that will need careful management between now and closing. Regulatory approvals, court sign-off in Australia, and the execution of cancellation deeds for unlisted options round out the remaining conditions precedent.
Smaller holders have a practical exit route available. Those owning 50,000 or fewer shares or options can use a sale facility, under which an appointed agent will sell their future Critical Metals shares in the market and remit the net cash proceeds instead.
Market Pricing Still Leaves Room
The market's verdict on the merger's probability remains visible in the share price, though the picture is mixed. Over seven trading days, the stock advanced 5.44 percent, closing Monday at €0.1900. The longer-term numbers are more striking: the shares have gained 273.73 percent over the past twelve months and are up 110.38 percent since the start of the year.
Yet the gap to the 52-week high of €0.3055, set in early June, still stands at roughly 37.8 percent — a persistent discount that suggests the market has not fully priced in the deal's completion. The spread reflects the inherent uncertainties that remain: shareholder approval, the Australian court's blessing, and the timing of various regulatory clearances could all push the targeted second-half 2026 closing date further out.
There is also the question of what the fixed exchange ratio actually delivers. Since the consideration is denominated in Critical Metals shares, the ultimate value European Lithium holders receive will swing with the Nasdaq-listed stock's price and the Australian dollar-US dollar exchange rate — variables entirely beyond the company's control. For now, with Greenland's approval secured and a Boston fund holding a 5 percent stake, the pieces are in place for a September conclusion, but the final act has yet to be written.
Ad
European Lithium Stock: New Analysis - 11 August
Fresh European Lithium information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
